These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26261924)

  • 1. [Hypoparathyroidism].
    Koschker AC; Burger-Stritt S; Hahner S
    Dtsch Med Wochenschr; 2015 Aug; 140(16):1195-7. PubMed ID: 26261924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini-review: new therapeutic options in hypoparathyroidism.
    Cusano NE; Rubin MR; Sliney J; Bilezikian JP
    Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone therapy for hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.
    Winer KK; Yanovski JA; Sarani B; Cutler GB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3480-6. PubMed ID: 9768650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTH treatment in hypoparathyroidism.
    Sikjaer T; Rejnmark L; Mosekilde L
    Curr Drug Saf; 2011 Apr; 6(2):89-99. PubMed ID: 21524246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life in Hypoparathyroidism.
    Vokes TJ
    Endocrinol Metab Clin North Am; 2018 Dec; 47(4):855-864. PubMed ID: 30390818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
    Bislev LS; Sikjaer T; Rejnmark L
    Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.
    Angelopoulos NG; Goula A; Tolis G
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):50-4. PubMed ID: 17286236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of parathyroid hormone in hypoparathyroidism.
    Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
    J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report.
    Hod T; Riella LV; Chandraker A
    Clin Transplant; 2015 Nov; 29(11):951-7. PubMed ID: 26331695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide.
    Díaz-Soto G; Mora-Porta M; Nicolau J; Perea V; Halperin I; Puig-Domingo M
    Horm Metab Res; 2012 Sep; 44(9):708-10. PubMed ID: 22473758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.
    Linglart A; Rothenbuhler A; Gueorgieva I; Lucchini P; Silve C; Bougnères P
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3308-12. PubMed ID: 21865375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of recombinant PTH on management of hypoparathyroidism: a systematic review.
    Ramakrishnan Y; Cocks HC
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):827-35. PubMed ID: 25567344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.
    Saraiva M; Chaves AC; Assunção G; Saraiva J; Carvalho R
    Am J Case Rep; 2021 Aug; 22():e931739. PubMed ID: 34389697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natpara for the treatment of hypoparathyroidism.
    Marcucci G; Della Pepa G; Brandi ML
    Expert Opin Biol Ther; 2016 Nov; 16(11):1417-1424. PubMed ID: 27689826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving management of severe hypoparathyroidism: a case series.
    Ugalde-Abiega B; Lamas Oliveira C; Alfaro Martínez JJ; Meizoso-Pita O; Sevillano Collantes C; Gomez García I; Perez Rodríguez A; Huguet I
    Hormones (Athens); 2022 Mar; 21(1):71-77. PubMed ID: 34647284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
    J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Expert Rev Endocrinol Metab; 2015 Jan; 10(1):5-13. PubMed ID: 25705243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.